VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652682
Sex: M
Age:
State: CT

Vax Date: 03/19/2021
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Slight chill on his shoulder; This is a spontaneous report from a contactable consumer or other non-professional healthcare professional (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration date was not provided), via an unspecified route of administration on 19Mar2021 as concentrated, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, the caller called to report adverse event for his friend with the Pfizer COVID Vaccine. The caller stated that, he had the Pfizer injection and nothing happened to him, it was great. The caller ran a triage for a while in a rehab hospital in a correctional facility. Rehab clients would come in and he would take their temperature, vitals, do intake and get them ready for rehab. He was not a nurse, doctor or pharmacist. For himself the only adverse effect was a slight chill on his shoulder for 4 to 5 hours on an unspecified date in Mar2021. He received it on 19Mar2021 and it could have been the weather. It doesn't matter. The caller declined to do a report for himself about his experience with the Pfizer COVID vaccine. The outcome of the event was recovered on an unspecified date in Mar2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652683
Sex: M
Age:
State: AZ

Vax Date: 04/05/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Heart palpitations; Hard time breathing; This is a spontaneous report from a Pfizer sponsored program report received from a contactable consumer or other non-health care professional. A 66-year old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number EW0150), via an unspecified route of administration in the arm right on 05Apr2021 at a 11:30 (at the age of 66-year-old) as a dose 1, single for COVID-19 immunization. The patient medical history included ongoing cholesterol (Verbatim: Cholesterol). Concomitant medications were not reported. On an unspecified date, the patient experienced heart palpitations, congestion and hard time breathing. The patient stated that he was congested and never had this before and it was hard to breathe. He said he worked out and ran. All the events were non-serious. The outcome of all the events was not recovered. Follow-Up (20Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness: Cholesterol (Verbatim: Cholesterol)

ID: 1652684
Sex: F
Age:
State: AL

Vax Date: 06/04/2021
Onset Date: 06/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Extreme nausea,; Diarrhoea; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Jun2021 at 10:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date in Jun2021 the patient experienced extreme nausea, diarrhoea and vomiting. The clinical outcome of the events extreme nausea, diarrhoea and nausea were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652685
Sex: M
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: I have been experiencing sexual arousal (think puberty) for a few hours; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 36-year) on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication includes Bunch of vitamins the patient received within 2 weeks of vaccination. Historical vaccine includes first dose of BNT162B2 in left arm administered on 20May2021 at 07:00 PM for COVID-19 immunization; the noticed light tingling in his head - super weird after the first dose. No allergies were reported. No COVID prior vaccination was reported. The patient not tested COVID post vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received no other medications in four weeks. On an unspecified date in 2021 the patient experienced sexual arousal (think puberty) for a few hours. It was reported by the patient that "Nothing terrible, but within seconds to a few minutes after getting the first dose he noticed light tingling in his head - super weird. Also, the first 4-6 hours after the first and now second shot he has been experiencing sexual arousal (think puberty) for a few hours. Not a big deal, but interesting and he thought this info may be valuable." No treatment was received for the adverse event by the patient. The clinical outcome of the event was unknown. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1652686
Sex: M
Age:
State: TN

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Light tingling in my head - super weird; Light tingling in my head - super weird; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: unknown) via an unspecified route of administration in left arm on 20May2021 at 07:00 PM (at the age of 36-years-old) as dose 1, single for COVID-19 immunisation. Medical history and concomitant medication were not reported. No known allergies. the patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine and the patient received Bunch of vitamins within 2 weeks of vaccination. Nothing terrible, but within seconds to a few minutes after getting the first dose on 20May2021 at 07:00 PM, I noticed light tingling in my head - super weird. Not a big deal, but interesting and I thought this info may be valuable. No treatment received for adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The report was non serious. Outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652687
Sex: F
Age:
State:

Vax Date: 05/21/2021
Onset Date: 05/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Lump felt in arm pit days after receiving first dose; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0182) via an unspecified route of administration in the left arm on 21May2021 at 16:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021, the patient experienced lump felt in arm pit days after receiving first dose. No therapeutic measures were taken as a result of the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lump felt in arm pit was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652688
Sex: F
Age:
State: IA

Vax Date: 06/08/2021
Onset Date: 06/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Blurred vision; dizziness; Swollen lymph node in left underarm; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0177) via an unspecified route of administration in the left arm on 08Jun2021 at 16:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety and penicillin allergy. The patient received other medications within two weeks of vaccination, names were unspecified. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0183) via an unspecified route of administration in the left arm on 18May2021 at 16:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Jun2021 at 14:15, the patient experienced blurred vision, dizziness, swollen lymph node in left underarm. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events blurred vision, dizziness, swollen lymph node in left underarm was recovered on an unspecified in Jun2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Penicillin allergy

ID: 1652689
Sex: M
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: sore arm; muscle soreness, like an ache "on and off" and then it went away; had an ache or pressure when lifting her arm up that happened sporadically throughout the day in the same muscle group; picking things up and dropping things; having a tingling feeling off and on but that went away; some weakness to her hand on the side of her injection; tired; Pain at the injection site; feel discomfort at the injection site; This is a spontaneous report from a contactable consumer (patient). This is the first case out of the 2 cases. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date as a dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sore arm, muscle soreness, like an ache "on and off" and then it went away, had an ache or pressure when lifting her arm up that happened sporadically throughout the day in the same muscle group, picking things up and dropping things, having a tingling feeling off and on but that went away, some weakness to her hand on the side of her injection, tired and feel discomfort at the injection site. Reporter was asking "Is this something that happens to other people?" Reporter reported that she received her second dose of the Covid vaccine on Apr18 and from the time she got the injection she started having a sore arm. Reporter reported having muscle soreness, like an ache "on and off" and then it went away. Reporter reported that 2 weeks ago the soreness started to come back, same place, same muscle, same ache. She had an ache or pressure when lifting her arm up that happened sporadically throughout the day in the same muscle group. The first vaccine dose was not painful, but the second shot was more painful and may have been given with a larger needle. She went on to report that "she had 5,6,7 days where I was picking things up and dropping things" and reported having a tingling feeling off and on but that went away. Reporter also reported having some weakness to her hand on the side of her injection. Patient had Soreness to her arm, tiredness and pain at the injection site. There was no product complaint reported. The clinical outcome of all the events were unknown. Information on the lot/batch number has been requested. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021684418 same patient/drug/similar event, different patient;US-PFIZER INC-2021687674 same patient/drug/similar event, different patient;US-PFIZER INC-2021687675 same patient/drug/similar event, different patient;US-PFIZER INC-2021687677 same patient/drug/similar event, different patient

Other Meds:

Current Illness:

ID: 1652690
Sex: F
Age:
State: FL

Vax Date: 05/20/2021
Onset Date: 06/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Cansancio; dolor de cuerpo intenso; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 20May2021 at 14:30(at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfa and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jun2021 at 02:30 the patient experienced fatigue, abdominal pain intense and full-bodied. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of both the events fatigue, abdominal pain intense and full-bodied was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652691
Sex: M
Age:
State: MA

Vax Date: 06/07/2021
Onset Date: 06/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Extreme fatigue; flu-like symptoms; swollen arm pit (left); painful arm pit (left); headache; low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 07Jun2021 at 17:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 17May2021 at 17:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Jun2021 at 11:00, the patient had extreme fatigue, swollen and painful arm pit (left) flu-like symptoms, headache, low grade fever. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, swollen and painful arm pit (left) flu-like symptoms, headache, low grade fever was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652692
Sex: M
Age:
State: CA

Vax Date: 05/28/2021
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: PLEURISY.TWO WEEKS AFTER THE 1ST SHOT, I WAS GETTING IN MY CAR AND HAD A SUDDEN SHARP PAIN IN MY CHEST THAT HURT SO BAD I COULD BARELY MOVE MY SHOULDERS AND ARMS AND HAD A HARD TIME BREATHING. IT DI; PLEURISY.TWO WEEKS AFTER THE 1ST SHOT, I WAS GETTING IN MY CAR AND HAD A SUDDEN SHARP PAIN IN MY CHEST THAT HURT SO BAD I COULD BARELY MOVE MY SHOULDERS AND ARMS AND HAD A HARD TIME BREATHING. IT DI; PLEURISY.TWO WEEKS AFTER THE 1ST SHOT, I WAS GETTING IN MY CAR AND HAD A SUDDEN SHARP PAIN IN MY CHEST THAT HURT SO BAD I COULD BARELY MOVE MY SHOULDERS AND ARMS AND HAD A HARD TIME BREATHING. IT DI; This is a spontaneous report from a contactable consumer or other non-health care professional. A 21-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EW017, Expiration date: Unknown), via an unspecified route of administration, in Left Arm on 28May2021 17:00 (at the age of 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included wheezing, food allergy NUTS, POLLEN, PET DANDER, SHELLFISH, seasonal allergy, allergy to animal, food allergy from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. On 10Jun2021 04:30, the patient had experienced pleurisy. Two weeks after the 1st shot, patient was getting in my car and had a sudden sharp pain in her chest that hurt so bad patient could barely move her shoulders and arms and had a hard time breathing. It dissipated a bit after 20 minutes, but when patient slept, patient turned in my sleep and again the sharp pain hit again and patient could not sleep. patient tried to get comfortable and slept the rest of the night. patient have not seen a medical professional yet because a close family friend had the exact same reaction 2 weeks after her moderna vaccine and walked me through it. She had gone to urgent care and they told her it was pleurisy, which lasted a few days for her. Hopefully it did not get more severe. Outcome of events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652693
Sex: F
Age:
State:

Vax Date: 06/07/2021
Onset Date: 06/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210610; Test Name: COVID-19 virus test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Rash, Urticaria

Symptoms: swollen mouth; swollen glands; sore throat; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the right arm on 07Jun2021 at 08:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included milk allergy (Dairy allergy), gluten intolerance (Wheat allergy). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 09Jun2021 at 22:00, the patient experienced swollen glands, sore throat and swollen mouth. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with BENADRYL. On 10Jun2021, the patient underwent COVID-19 virus test (Nasal swab) and the result was negative. The clinical outcome of the events swollen glands, sore throat and swollen mouth was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Gluten intolerance (wheat allergy); Milk allergy (dairy allergy)

ID: 1652694
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Thigh numbness, 17 days after 2nd dose; Arm heaviness; Lower back pain on and off,; hip soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unknown date the patient experienced thigh numbness. On an unknown date 17 days after 2nd dose vaccination, the patient experienced arm heaviness, lower back pain on and off and hip soreness. The clinical outcome of the events thigh numbness, arm heaviness, lower back pain on and off and hip soreness was unknown at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652695
Sex: F
Age:
State: CT

Vax Date: 04/15/2021
Onset Date: 06/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 15:30 (at the age of 40-year-old) as a single dose for COVID-19 immunization. Medical history included COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) for unknown indication from unspecified date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 16:30, the patient experienced shingles. The event resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of the event and included treatment with medication. The clinical outcome of the event shingles was not recovered at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds: BUPROPION

Current Illness:

ID: 1652696
Sex: M
Age:
State:

Vax Date:
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Stabbing pain in lungs; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Jun2021, at 22:00 the patient experienced stabbing pain in lungs. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as the result of adverse events. The clinical outcome of the event stabbing pain in lungs was not resolved at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652697
Sex: F
Age:
State: NC

Vax Date: 06/09/2021
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: body aches; Fever; swollen lymph nodes in armpit; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO191) via an unspecified route of administration in the right arm on 09Jun2021 at 00:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as non that she was aware of. Concomitant medications was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO177) via an unspecified route of administration in the right arm on 19May2021 at 00:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Jun2021 at 02:45, the patient experienced fever, swollen lymph nodes in armpit and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, swollen lymph nodes in armpit and body aches were resolving at the time of this report.

Other Meds:

Current Illness:

ID: 1652698
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: increased heart rate (120 resting); fever; chills; muscle fatigue; joint pain; migraines; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced increased heart rate (120 resting), fever, chills, muscle, fatigue, joint pain and migraines. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab test for COVID-19 on an unknown date and the result was found to be negative. The clinical outcome of the events increased heart rate (120 resting), fever, chills, muscle, fatigue, joint pain and migraines were resolved with sequelae on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652699
Sex: F
Age:
State: MA

Vax Date:
Onset Date: 05/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Both breasts were swollen; Both breasts were swollen, and very sensitive to the touch; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in left arm on an unknown date (at the age of 41-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in left arm on 25May2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID 19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18May2021, the patient had experienced both breasts were swollen and very sensitive to the touch. The patient had also reported that she experienced the event 2 weeks after receiving both shots. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported adverse events. The clinical outcome of the events, both breasts were swollen and very sensitive to the touch was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652700
Sex: F
Age:
State:

Vax Date: 06/07/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: I was supposed to get my second one on April the 18th but I was in the hospital so I couldn't get it; I was supposed to get my second one on April the 18th but I was in the hospital so I couldn't get it; I am on oxygen.; I have a bad rotator cuff in my right shoulder and it is been, it felt swollen; shoulder lets me know what's there, it feels like a 'bone' strap across my shoulder; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0196, Expiration date was not reported), dose 2 via an unspecified route of administration on 07Jun2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took dose 1 of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT: ER2613) on 26Mar2021 for covid-19 immunization. On an unspecified date the patient experienced she was supposed to get her second one on 18Apr2021 but she was in the hospital so she couldnt get it, she is on oxygen (po2), she has a bad rotator cuff in her right shoulder, and it is been, it felt swollen, shoulder lets her know what's there, it feels like a 'bone' strap across her shoulder (musculoskeletal discomfort). Patient stated, if she had to explain it and she didnt know if that would be a Covid side effect or just her rotator cuff acting that. The outcome of events was unknown.

Other Meds:

Current Illness:

ID: 1652701
Sex: M
Age:
State: MD

Vax Date: 06/08/2021
Onset Date: 06/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Headache; Vomiting; Fever; Chills; This is a spontaneous report from a contactable 13-year-old male consumer (patient) reported for himself that received bnt162b2 (PFIZER COVID 19, Solution for injection, Lot Number: EWO180), via an unspecified route of administration, administered in arm left on 08Jun2021 11:45 (at the age of 13-year-old) as dose number unknown, single for covid-19 immunisation. Medical history was none. No known allergies. No other vaccine in four weeks. Also, no other medications in two weeks. Prior to vaccination, patient had not diagnosed with Covid. Post vaccination, the patient had not tested Covid. There were no concomitant medications. Facility type vaccine was pharmacy or drug store. The patient experienced headache, vomiting, fever and chills on 09Jun2021 00:15. No treatment received for adverse events. The outcome of events was resolved on Jun2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652702
Sex: M
Age:
State: NY

Vax Date: 04/08/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: A week or 2 after the 2nd shot experienced sporadic heart palpitations.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Apr2021 at 16:00(at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021, a week or two after the second shot the patient experienced sporadic heart palpitations. They have since diminished. The primary care doctor ran tests on the patient. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the even sporadic heart palpitations was recovering. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652703
Sex: F
Age:
State: KS

Vax Date: 06/07/2021
Onset Date: 06/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: ear ringing; Fever; headache; arm soreness; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 07Jun2021 at 18:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 17May2021 at 12:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Jun2021 the patient experienced fever, headache, arm soreness and fatigue. On 10Jun2021, on day 3, the patient experienced ear ringing. No therapeutic measures were taken as a result of the reported events. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, headache, arm soreness, fatigue and ear ringing were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652704
Sex: F
Age:
State: MI

Vax Date: 02/18/2021
Onset Date: 02/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202002; Test Name: COVID-19; Result Unstructured Data: Test Result:had covid-19; Comments: I believe I had covid-19 in Feb2020

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Severe, debilitating, crushing, headache; debilitating; migraine-type; vision issues; sensivity to light; noise; arm swelling; hot; red; nausea; dizziness; muscle aches; This is a spontaneous report from a contactable consumer or other non-HCP. A 65-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267; Expiration Date: 31May2021), intramuscular, administered in Left Arm on 18Feb2021 as DOSE 2, SINGLE (at the age of: 65-year-old) for covid-19 immunization. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution injection, Lot number: EL3247) intramuscular, administered in Left Arm on 20Jan2021 (at the age of: 65-year-old) for covid-19 immunization. Medical history included psoriatic arthropathy from 1980 and ongoing, fibromyalgia, covid-19 from Feb2020 and she believes she had covid-19 in Feb2020. There were no concomitant medications. The patient previously took statins and experienced drug hypersensitivity, bnt162b2 for covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered is mentioned as Hospital. Vaccine was not administered at Military facility. Other vaccine in fourweeks as Pfizer COVID 19 on 04Feb2021. Prior to vaccination, Unknown about the patient was diagnosed with COVID-19 and since the vaccination, the patient has been not tested for COVID-19. On 20Feb2 021 the patient experienced severe, debilitating, crushing, headache, debilitating, migraine-type, vision issues, sensivity to light, noise, arm swelling, hot, red, nausea, dizziness, muscle aches. The patient underwent lab tests and procedures which included sars-cov-2 test: had covid-19 on Feb2020 I believe I had covid-19 in Feb2020. Therapeutic measures were taken as Pain med, office visits, MRIs as a result of severe, debilitating, crushing, headache. The outcome of event severe, debilitating, crushing, headache was not recovered while outcome of rest all events unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness: Psoriatic arthritis

ID: 1652705
Sex: F
Age:
State: MI

Vax Date: 01/27/2021
Onset Date: 02/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210208; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: my neck swelled up; lumps and bumps became very hard and painful; lumps and bumps became very hard and painful; lumps and bumps became very hard and painful; This is a spontaneous report from a contactable consumer (Patient) or other non-health care professional. A 73-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 27Jan2021 (Age at vaccination: 73 years) as single dose for COVID-19 immunisation. Medical history included chronic lymphocytic leukaemia from an unknown date and unknown if ongoing. The patient previously took benadryl and experienced drug hypersensitivity. The patient previously received first dose of bnt162b2(lot number: EL9261), administered in left arm on 27Jan2021 09:00 AM for COVID-19 immunisation. Patient received 1st dose on 27Jan2021 at 9:00 in left arm with lot number EL9261. Patient did not receive any other vaccine in four weeks. Patient received 7 prescrip-tions and 4 OTC in two weeks. Patient did not have COVID prior vaccination. Patient tested COVID post vaccination. The patient experienced my neck swelled up, lumps and bumps became very hard and painful on 18Feb2021 at 08:00. The patient underwent lab tests and procedures which included sars-cov-2 test which was negative on 08Feb2021. Primary care doctor and oncologist waited for a while, we then tried round of Rituxan. We were trying the chemotherapy, Treanda. Lump were quite painful, and she have not felt well since 17Feb. The outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652706
Sex: F
Age:
State: AL

Vax Date: 04/02/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: tingling feeling on the whole left side of head, not face, above ear on left side only; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 02Apr2021 at 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease and heart issues. The patient had no known allergies. Concomitant medication include thyroid (ARMOUR THYROID) from an unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced tingling feeling on the whole left side of her head, not face, above ear on left side only. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event tingling feeling on the whole left side of head, not face, above ear on left side only was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ARMOUR THYROID

Current Illness:

ID: 1652707
Sex: F
Age:
State: CO

Vax Date: 05/25/2021
Onset Date: 05/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Nosebleed; Mysterious bruising on legs; fatigue; Vertigo; Ringing in ears; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0177) via an unspecified route of administration in the right arm on 25May2021 at 15:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ethinylestradiol, norgestimate (TRI LINYAH) from an unknown date taken for birth control. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021 at12:00 since receiving the vaccine, the patient experienced fatigue, vertigo and ringing in the ears. On an unknown date in Jun2021, at the time of this report, the patient had a nosebleed for the first time in life seemed for no reason and also noticed mysterious bruising on legs. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events fatigue, vertigo, ringing in ears, nosebleed and mysterious bruising on legs were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: TRI LINYAH

Current Illness:

ID: 1652708
Sex: F
Age:
State: OR

Vax Date: 05/16/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: headache; tiredness; large outbreak of hives on my legs; After a week a sudden pain came to the back of my right leg; Sore in joints; tingling/numbness in legs/tingling in hands; numbness in legs; Pain had been intense and made it hard to walk, take stairs, bend, etc.; Pain had been intense and made it hard to walk, take stairs, bend, etc.; Feels like arthritis overnight; This is a spontaneous report from a contactable consumer (patient). A 38-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0185, Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 16May2021 18:30 (at the age of 38-years-old) as dose 1, single for covid-19 immunisation in other facility. No other vaccine was administered in four weeks. No other medications were given in two weeks. The patient did not have covid prior vaccination. The patient was not tested for covid post vaccination. The patient did not have known allergies. Medical history included covid-19 from Mar2020 to an unknown date. There were no concomitant medications. On 17May2021 at 07:00, the patient experienced headache, tiredness, large outbreak of hives on her legs, after a week a sudden pain came to the back of her right leg, sore in joints, tingling/numbness in legs/tingling in hands, numbness in legs, pain had been intense and made it hard to walk, take stairs, bend, etc and feels like arthritis overnight. The events result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment was given for the events. The outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652709
Sex: M
Age:
State: CA

Vax Date: 06/10/2021
Onset Date: 06/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Headache like head pulsing; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration in left arm on 10Jun2021 at 00:30 (at the age of 33-year-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: unknown) via an unspecified route of administration in left arm on 13May2021 (at the age of 33-year-old) at single dose for COVID-19 immunisation. On 12Jun2021 at 08:30, the patient experienced headache like head was pulsing and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events was not recovered. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652710
Sex: M
Age:
State: MA

Vax Date: 06/10/2021
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Arm was sore; Chills; vomited; Fever; headache; This is a spontaneous report from a contactable consumer. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 10Jun2021 at 16:15 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included headache, nausea, vomiting, COVID-9. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 19May2021 at (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 10Jun2021 at 16:30, the patient experienced arm was sore after receiving the vaccine. On 10Jun2021, the patient experienced about 12 hours after receipt of the vaccine, woke up with chills and vomited, about 2 hours later fever, headache, chills and vomited a second time. Patient reported that by 6pm on 11June, patient had no symptoms was feeling normal and eating regularly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events arm was sore, chills and vomited, headache was recovered on 11Jun2021 at 18:00. The lot number for BNT162b2 was not provided and will be requested during follow up

Other Meds:

Current Illness:

ID: 1652711
Sex: F
Age:
State: NC

Vax Date: 06/12/2021
Onset Date: 06/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Fever; Chills; Muscle ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 12Jun2021 at 12:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient previously had penicillin for unknown indication and experienced penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 22May2021 at 12:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient previously took codeine (MANUFACTURER UNKNOWN), nitrofurantoin (MACRODANTIN) and pethidine hydrochloride (DEMEROL), all for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Jun2021 at 08:00, the patient experienced fever, chills, muscle aches, fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, chills, muscle aches, fatigue was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652712
Sex: M
Age:
State: MO

Vax Date: 06/11/2021
Onset Date: 06/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210611; Test Name: body temperature; Result Unstructured Data: Test Result:103 Units:[degF]

Allergies:

Symptom List: Injection site pain

Symptoms: fever; fatigue; This is a spontaneous report from a contactable consumer. A elderly male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 11Jun2021 as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19.It was unknown if the patient received any other medications within 2 weeks of vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the vaccination. On 11Jun2021, the patient experienced fever for approximately 48 hours and fatigue. On the same day, the patient underwent body temperature test and the result was 103F. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the event fever and fatigue were resolving at the time of report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652713
Sex: F
Age:
State: AZ

Vax Date: 06/08/2021
Onset Date: 06/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210609; Test Name: fever; Result Unstructured Data: Test Result:99.0 (unspecified units); Comments: low grade fever

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: she continued to not feel well; low grade fever to 99.0; the day after that she developed a sore throat; stuffy nose; mild cough; This is a spontaneous report from a contactable consumer (patient's parent). A 13 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW978) via an unspecified route, administered in Right arm on 08Jun2021 (13-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient was non-pregnant at time of vaccination. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. Facility type vaccine was reported as pharmacy or drug store. The patient was not diagnosed with Covid prior to vaccination. The patient was not tested for Covid post vaccination. The patient had not received any other vaccine in four weeks of Covid-19 vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8734) via an unspecified route, administered in Right arm on 17May2021 (12-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. On 09Jun2021 (the day after the vaccination), the reporter's daughter developed a low-grade fever to 99.0, which responded to ibuprofen, the day after that she developed a sore throat, stuffy nose and mild cough, with a very low-grade fever. On 10Jun2021, she continued to not feel well the next day with similar symptoms, and then started to become slightly better by the 4th day after the shot. By the 5th day, today she felt almost well. The patient underwent lab tests and procedures which included body temperature: 99.0 (units unspecified), low grade fever on 09Jun2021.No treatment medications were received for the events sore throat, stuffy nose, cough and not feel well. The outcome of the events was recovering. Follow-up attempts are completed. No further information was expected.

Other Meds:

Current Illness:

ID: 1652714
Sex: F
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Face has been brilliant red since shortly after receiving 2nd vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6203) via an unspecified route of administration in the left arm on 10Mar2021 at 11:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications includes atorvastatin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), timolol (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and B all for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: el3247) via an unspecified route of administration in the left arm on 17Feb2021 at 12:00 as a single dose for COVID-19 immunisation. On 19Mar2021, shortly after receiving 2nd vaccine, the patient face had been brilliant red. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event face has been brilliant red was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; LEVOTHYROXINE; TIMOLOL; CALCIUM

Current Illness:

ID: 1652715
Sex: F
Age:
State: SC

Vax Date: 06/11/2021
Onset Date: 06/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: There is muscle pain going into my lymph nodes and breast tissue; There is muscle pain going into my lymph nodes and breast tissue; There is muscle pain going into my lymph nodes and breast tissue; This is a spontaneous report from a contactable consumer, the patient A 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 11Jun2021 at 15:30(at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, penicillin allergy, and COVID-19. Concomitant medication was not reported. The patient previously received meningococcal vaccine (MANUFACTURER UNKNOWN) on 28May2021 for immunisation within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Jun2021 at 23:45 the patient experienced muscle pain going into her lymph nodes and breast tissue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event muscle pain going into lymph nodes and breast tissue was not recovered. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652716
Sex: F
Age:
State: TX

Vax Date: 06/11/2021
Onset Date: 06/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Tired; Hot; This is a spontaneous report from a contactable other healthcare professional, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Jun2021 at 15:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included graves' disease and hyperthyroidism. The patient had known allergies to food, gluten, sugar and diary. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) and thiamazole (METHIMAZOLE); both from unknown dates for unspecified indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 11Jun2021 at 20:30, the patient reported that she felt tired and hot. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tired and hot was resolving at the time of this report. The batch/lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: ATENOLOL; METHIMAZOLE

Current Illness:

ID: 1652717
Sex: F
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: shingles; skin rash appeared on left hip / lower abdomen area; skin pain across left hip/ skin felt painful with pressure change (i.e., when touched, or when pressure from compression is lifted). Pain continuedthrough the week, spreading from hip across left lower back; Skin felt sensitive; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 at 09:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies to shellfish, tree nuts, stone fruits and some alcohols. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 11Apr2021, the patient started to feel skin pain across left hip, skin felt sensitive and painful with pressure change (i.e., when touched, or when pressure from compression was lifted). Pain continued through the week, spreading from hip across left lower back. On 18Apr2021, a skin rash appeared on left hip/lower abdomen area. On 20April2021, patient saw physician, who diagnosed the rash and pain as shingles and immediately started valacyclovir. Therapeutic measures were taken as a result of the events which included treatment with valacyclovir (VALTREX). The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event skin felt sensitive and shingles was resolved on an unknown date in 2021 and outcome of the event skin rash appeared on left hip/lower abdomen area and skin pain/pain continued through the week, spreading from hip across left lower back was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652718
Sex: F
Age:
State: OR

Vax Date: 06/11/2021
Onset Date: 06/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:increased

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: increased heart rate that continued to occur intermittently over the next 24 hours; Injection site redness; Injection site swelling; Injection site heat; This is a spontaneous report from a contactable nurse, the patient. A 50-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0173), via an unspecified route of administration in the arm left on 11Jun2021 09:45 as dose 1, single (at the age of 50-years-old) for covid-19 immunization. Medical history was not reported. Concomitant medications included ergocalciferol (VITAMIN D), cetirizine hydrochloride (ZYRTEC), multivitamins and tocopherol (VITAMIN E). The patient previously took demerol and experienced hallucination. On 11Jun2021 15.30, the patient experienced increased heart rate that continued to occur intermittently over the next 24 hours, injection site redness, injection site swelling and injection site heat. The patient did not received the treatment for the events. The patient had tested positive for the covid prior to the vaccination but not tested for post vaccination. The patient did not received the any other vaccine in four weeks. The outcome of the events was unknown. Follow-up attempts were completed. No further information was expected.

Other Meds: VITAMIN D [ERGOCALCIFEROL]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN E [TOCOPHEROL]

Current Illness:

ID: 1652719
Sex: F
Age:
State: KY

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: swollen; This spontaneous report received from a contactable consumer based on the information received by Pfizer (Reference ID: NVSC2021US106430). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history included swelling. The patient concomitant medications were not reported (unknown medication for swelling). On an unspecified date, the patient had swollen due to stopping medication after receiving her Covid-19 vaccine.

Other Meds:

Current Illness:

ID: 1652720
Sex: F
Age:
State: AZ

Vax Date: 06/09/2021
Onset Date: 06/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: upset stomach; nausea; mild asthma; excessive sweating in feet; dull headache; fatigue; pain in the arm where the injection was placed; low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the right arm on 09Jun2021 at 10:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma, which was still ongoing. The patient had allergy to penicillin and eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took gatifloxacin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. Concomitant medication included multivitamin from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Jun2021 at 10:45, the patient experienced mild asthma, excessive sweating in feet, dull headache, fatigue, pain in the arm where the injection was placed and low grade fever. On 10Jun2021, the patient experienced nausea. On 11Jun2021, the patient experienced upset stomach. The events resulted in emergency room/department visit or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event(s). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of mild asthma, excessive sweating in feet, dull headache, fatigue, pain in the arm where the injection was placed, low grade fever, nausea and upset stomach was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness: Asthma (Mild asthma)

ID: 1652721
Sex: F
Age:
State:

Vax Date: 06/10/2021
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210610; Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: fever of 102

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: started running a fever of 102 by 10 pm; flu - pure poison; feel like crap; This is a spontaneous report from a contactable consumer. A 54 year old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 10Jun2021 (at the age of 54 year old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and COVID-19. The patient received an unspecified medication within two weeks of vaccination which was unspecified. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 20May2021 (at the age of 54 year old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. On 10Jun2021 at 22:00, the patient had running a fever of 102 by 10 pm, like had the flu, pure poison and missed another day of work and had been in bed for 24 hours and still felt like crap. The patient hope by next day that would pass. On 10Jun2021, the patient checked body temperature and the result was 102(unspecified units). The clinical outcome of the events were unknown at the time of this report. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652722
Sex: F
Age:
State: GA

Vax Date: 05/24/2021
Onset Date: 05/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: flu like symptoms with increased bruising all over body; flu like symptoms with increased bruising all over body; This is a spontaneous report from a contactable nurse, patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 24May2021 at 14:30(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, hypothyroidism, and hypertension. Patient had several unspecified allergies. The patient received unspecified other medications within two weeks of vaccination. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26May2021 at 02:00, the patient experienced flu like symptoms with increased bruising all over body. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event flu like symptoms with increased bruising all over body was recovered with sequelae on an unknown date in 2021, at the time of this report. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652723
Sex: F
Age:
State: KS

Vax Date: 06/01/2021
Onset Date: 06/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Tired; Headache; Sneezing; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the right arm on 01Jun2021 (at the age of 21-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes type one and known allergy to gluten. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Jun2021, the patient was very tired a day after getting vaccine, had a few headaches and had been sneezing for the last few days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of very tired a day after getting vaccine, had a few headaches and had been sneezing for the last few days were recovered on unknown date in Jun2021. The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652724
Sex: F
Age:
State: CA

Vax Date: 06/12/2021
Onset Date: 06/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Flu like symptoms. Mostly headache, nausea, and feeling hot; Flu like symptoms. Mostly headache, nausea, and feeling hot.; Flu like symptoms. Mostly headache, nausea, and feeling hot.; Flu like symptoms. Mostly headache, nausea, and feeling hot.; This is a spontaneous report from a non-contactable consumer. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 12Jun2021 at 08:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in May2021 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Jun2021 at 08:00, the patient experienced flu like symptoms, mostly headache, nausea, and feeling hot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, mostly headache, nausea, and feeling hot was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652725
Sex: M
Age:
State: CA

Vax Date: 06/12/2021
Onset Date: 06/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Flu like symptoms; Headache; Nausea; Feeling hot; This is a spontaneous report from a contactable consumer. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 12Jun2021 at 08:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on an unknown date (at an unknown age) as a single dose for COVID-19 immunisation. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Jun2021, the patient experienced flu like symptoms, mostly headache, nausea and feeling hot. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, headache, nausea and feeling hot were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652726
Sex: F
Age:
State: NJ

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210328; Test Name: Blood pressure; Result Unstructured Data: Test Result:Dropped

Allergies:

Symptom List: Vomiting

Symptoms: Heart palpitations; Dizzy/Light headed; Blood pressure dropped; Tachycardia; The initial safety information received was reporting only non-serious adverse drug reaction(s), Upon receipt of follow-up information on 09Aug2021, this case now contains serious adverse reaction(s). Information processed together. This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: ER8727; expiration date: 30Jun2021), intramuscularly administered in the left arm on 28Mar2021 15:15 (at the age of 65-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Medical history included hypothyroidism, sensitivity to cold medicines, and atrioventricular nodal reentrant tachycardia (AVRNT) from 2015 to 20Apr2021 (ablation done on 20Apr2021). Concomitant medications included thyroid (ARMOUR THYROID) and levothyroxine sodium (SYNTHROID). The patient previously took guaifenesin/phenylephrine hydrochloride (ENTEX) and sulindac (CLINORIL) and experienced drug allergy with both drugs. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN6205; expiration date: 30Jun2021) intramuscularly administered in the upper arm (unspecified which side) on 07Mar2021 15:00 (at the age of 65-years-old) as dose 1, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccinations within 4 weeks of the COVID vaccine. On 28Mar2021, the patient experienced heart palpitations, tachycardia, dizzy/light headed, and blood pressure dropped approximately 1 and a half to 2 hours after the vaccination. The heart palpitations and tachycardia lasted for 15 minutes. Therapeutic measures were not taken as result of the events. The outcome of events palpitations and tachycardia was recovered on 28Mar2021. The outcome of event dizziness was recovered on an unspecified date while the outcome of event blood pressure dropped was unknown. The event palpitations was reported as serious (important medical event). Follow-up attempts are completed. No further information is expected.

Other Meds: ARMOUR THYROID; SYNTHROID

Current Illness: Atrioventricular nodal reentrant tachycardia

ID: 1652727
Sex: F
Age:
State:

Vax Date: 06/09/2021
Onset Date: 06/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Swelling arm around injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the arm on 09Jun2021 at 10:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and other medication received within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jun2021, the patient experienced swelling arm around injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event swelling arm around injection site was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652728
Sex: F
Age:
State: NJ

Vax Date: 06/10/2021
Onset Date: 06/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Fever; chills; body ache; chest pain while breathing in; Dose number=1 27May2021/ Dose number=2 10Jun2021; Dose number=1 27May2021/ Dose number=2 10Jun2021; This is a spontaneous report from a contactable Other HCP (patient). A 41-years-old female non-pregnant the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection)via an unspecified route of administration, administered in Arm Left on 27May2021 at 03:00 PM (Batch/Lot number was not reported) as a Dose 1, Single and bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection,Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 10Jun2021 at 14:00 (at the age of 41-years-old) as a Dose 2,Single for COVID-19 immunization at Pharmacy or Drug Store. The patient medical history was not reported. Concomitant medication in two weeks included, birth control medications. Other vaccine received in four weeks was none. It was unknown whether the patient had covid prior vaccination. The patient was not tested for covid post vaccination. The patient had Dose number=1 27May2021/ Dose number=2 10Jun2021 (off label use and inappropriate schedule of product administration). On 11Jun2021 at 04:00, patient experienced fever, chills, body ache and chest pain while breathing in. Therapeutic measures were taken as a result of the events which included Anti-inflammatory medications. Events resulted in the Emergency room/department or urgent care. Outcome of off label use and inappropriate schedule of product administration were unknown whereas, rest of the events were recovering. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652729
Sex: F
Age:
State:

Vax Date: 06/07/2021
Onset Date: 06/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Congestion; dizziness; headaches; incontinence; severe lower leg pain; numbness in feet; tingling on face; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 07Jun2021 at 13:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included 2 heart mitral valve surgeries, Raynaud's disease, deviated septum and arthritis. The patient had allergies to sulfa drugs. Concomitant medications were not reported. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Jun2021 the patient experienced congestion, dizziness, headaches, incontinence, severe lower leg pain, numbness in feet and tingling on face. It happened within an hour of vaccine. Got better 2 days in between and on 3rd now having same side effects as the first day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events congestion, dizziness, headaches, incontinence, severe lower leg pain, numbness in feet and tingling on face were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652730
Sex: F
Age:
State: MA

Vax Date: 05/20/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210521; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Units:[degF]; Comments: 101 degrees Fahrenheit high fever (101 degrees Fahrenheit) At: 00:30

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fatigue; Severe body aches; Headache; Severe injection site pain; Chills; High fever (101 degrees Fahrenheit); This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 20May2021 at 12:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 29Apr2021 at 12:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21May2021 at 00:30, the patient experienced fatigue, severe body aches, headache, severe injection site pain, chills and high fever (101 degrees Fahrenheit). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, severe body aches, headache, severe injection site pain, chills and high fever (101 degrees Fahrenheit) were resolved on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652731
Sex: F
Age:
State:

Vax Date: 05/18/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Swollen gland in neck still there after almost 4 weeks; This is a spontaneous report from a contactable healthcare professional. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the arm left on 18May2021 at 10:15(at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the arm left on an unknown date in Apr2021 at 10:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19May2021, the patient experienced swollen gland in neck still there after almost 4 weeks. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event swollen gland in neck still there after almost 4 weeks was not recovered at the time of this report.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am